Clinical Trial Update: A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China. [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating the Ad5-EBOV Ebola vaccine in healthy adult Africans in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad5-EBOV (Ebola adenovirus vector vaccine)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Ebola Virus Disease | Phase 1 | Status: COMPLETED